1. Home
  2. GRCE vs JZ Comparison

GRCE vs JZ Comparison

Compare GRCE & JZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRCE
  • JZ
  • Stock Information
  • Founded
  • GRCE 2002
  • JZ 2011
  • Country
  • GRCE United States
  • JZ China
  • Employees
  • GRCE N/A
  • JZ N/A
  • Industry
  • GRCE
  • JZ Other Consumer Services
  • Sector
  • GRCE
  • JZ Real Estate
  • Exchange
  • GRCE NYSE
  • JZ Nasdaq
  • Market Cap
  • GRCE 30.9M
  • JZ 26.2M
  • IPO Year
  • GRCE N/A
  • JZ 2022
  • Fundamental
  • Price
  • GRCE $3.53
  • JZ $0.91
  • Analyst Decision
  • GRCE
  • JZ
  • Analyst Count
  • GRCE 0
  • JZ 0
  • Target Price
  • GRCE N/A
  • JZ N/A
  • AVG Volume (30 Days)
  • GRCE 75.8K
  • JZ 6.1K
  • Earning Date
  • GRCE 12-31-2024
  • JZ 09-27-2024
  • Dividend Yield
  • GRCE N/A
  • JZ N/A
  • EPS Growth
  • GRCE N/A
  • JZ N/A
  • EPS
  • GRCE N/A
  • JZ N/A
  • Revenue
  • GRCE N/A
  • JZ $50,810,288.00
  • Revenue This Year
  • GRCE N/A
  • JZ N/A
  • Revenue Next Year
  • GRCE N/A
  • JZ N/A
  • P/E Ratio
  • GRCE N/A
  • JZ N/A
  • Revenue Growth
  • GRCE N/A
  • JZ N/A
  • 52 Week Low
  • GRCE $1.98
  • JZ $0.53
  • 52 Week High
  • GRCE $4.97
  • JZ $2.89
  • Technical
  • Relative Strength Index (RSI)
  • GRCE N/A
  • JZ 34.71
  • Support Level
  • GRCE N/A
  • JZ $0.76
  • Resistance Level
  • GRCE N/A
  • JZ $0.97
  • Average True Range (ATR)
  • GRCE 0.00
  • JZ 0.06
  • MACD
  • GRCE 0.00
  • JZ -0.02
  • Stochastic Oscillator
  • GRCE 0.00
  • JZ 5.08

About GRCE GRACE THERAPEUTICS INC

Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.

About JZ Jianzhi Education Technology Group Company Limited

Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.

Share on Social Networks: